CYTK · Healthcare · $8.2B
$66.04+0.20%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“MYQORZO 매출이 3분기 연속 가속하며 이번 분기 3200만 달러를 기록했어요 — 직전 분기 1900만 달러 대비 뚜렷한 점프예요.”
In the company's words · 2026 2분기 earnings call